Experiment: 9G2N

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H COSY	0.85 mM non-labeled polypeptide, 1 % non-labeled sodium azide, 1 % non-labeled DSS	90% H2O/10% D2O	n.d.	7.1	1 atm	288	Bruker AVANCE III 700
2	2D 1H-1H TOCSY	0.85 mM non-labeled polypeptide, 1 % non-labeled sodium azide, 1 % non-labeled DSS	90% H2O/10% D2O	n.d.	7.1	1 atm	288	Bruker AVANCE III 700
3	2D 1H-1H NOESY	0.85 mM non-labeled polypeptide, 1 % non-labeled sodium azide, 1 % non-labeled DSS	90% H2O/10% D2O	n.d.	7.1	1 atm	288	Bruker AVANCE III 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	700

NMR Refinement
Method	Details	Software
simulated annealing		ARIA2alpha

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	20
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CcpNmr Analysis Assign	2.4.1.	CCPN
2	structure calculation	ARIA2alpha	2.3.1.	Rieping, W.
3	chemical shift assignment	CcpNmr Analysis Assign	2.4.1.	CCPN
4	peak picking	CcpNmr Analysis Assign	2.4.1.	CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.